Back to search

Article

Unveiling the signaling network of FLT3-ITD AML improves drug sensitivity prediction

2023-06-22

Abstract excerpt

<h4>Summary</h4> Currently, the identification of patient-specific therapies in cancer is mainly informed by personalized genomic analysis. In the setting of acute myeloid leukemia (AML), patient-drug treatment matching fails in a subset of patients harboring atypical internal tandem duplications (ITDs) in the tyrosine kinase domain of the FLT3 gene. To address this unmet medical need, here we develop a systems-b...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dceb9650-bfda-587c-b376-24631ffdf144
DOI
10.1101/2023.06.22.546072
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Unveiling the signaling network of FLT3-ITD AML improves drug sensitivity predictionDOI 10.1101/2023.06.22.546072
Select a neighboring publication to make it the new centre.